NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...

A Charleston woman was always short of breath and suffered from an undertreated heart problem. A new device at MUSC has her ...

The global prosthetic heart valve market is projected to be valued at USD 13,234.9 million by 2023 and is expected to grow ...

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to ...

The Global Transcatheter Cardiac Valve Replacement (THVR) Market, valued at USD 6.54 billion in 2023, is anticipated to grow significantly with a CAGR of 14.8% over the forecast period of 2024 to 2032 ...

Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

TTVR also led to "near elimination" of the TR, as 99.1% of people had moderate or less TR (and 95.3% mild or less) at the ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial ...